Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Chimerix Inc
(NQ:
CMRX
)
0.8900
+0.0500 (+5.95%)
Streaming Delayed Price
Updated: 2:06 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Chimerix Inc
< Previous
1
2
3
4
5
Next >
CMRX Stock Earnings: Chimerix Meets EPS, Beats Revenue for Q2 2024
August 13, 2024
CMRX stock results show that Chimerix met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Chimerix Reports Second Quarter 2024 Financial Results and Provides Operational Update
August 13, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market
August 06, 2024
EQNX::TICKER_START (NYSE:NNVC),(NASDAQ:BCRX),(NASDAQ:VERU),(NASDAQ:CMRX),(NASDAQ:SIGA) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
COVID-19
CMRX Stock Earnings: Chimerix Misses EPS for Q1 2024
May 01, 2024
CMRX stock results show that Chimerix missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Earnings Scheduled For February 29, 2024
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
Preview: Chimerix's Earnings
February 28, 2024
Via
Benzinga
Earnings Outlook For Chimerix
November 01, 2023
Via
Benzinga
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market
August 06, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Chimerix to Report Second Quarter 2024 Financial Results and Provide an Operational Update on August 13, 2024
August 06, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
4 Analysts Have This to Say About Chimerix
August 17, 2023
Via
Benzinga
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 05, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
May 30, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update
May 01, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024
April 24, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 16, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Appoints Marc D. Kozin to Board of Directors
March 21, 2024
Veteran Industry Executive Brings More Than 35 Years of Corporate Strategy Experience
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
February 29, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix to Present at TD Cowen 44th Annual Health Care Conference
February 27, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024
February 22, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Appoints Lisa Decker to Board of Directors
December 29, 2023
Seasoned Industry Executive Brings More Than 25 Years of Leadership and Business Development Experience
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer
December 04, 2023
Proven Leader Brings More Than 25 Years of Financial Experience
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 24, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer
November 16, 2023
Seasoned Executive Brings More Than 25 Years of Industry Leadership Experience in Oncology Commercialization and Corporate Business Development
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update
November 02, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023
October 26, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying
September 27, 2023
The Dow Jones closed lower by around 388 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Overview Of Value Stocks In The Healthcare Sector
September 18, 2023
Via
Benzinga
Chimerix to Participate in Upcoming Investor Conferences
September 05, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC201 Treatment of H3 K27M-Mutant Diffuse Midline Gliomas Published in "Cancer Discovery"
August 16, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
CMRX Stock Warning! Smart Biotech Investors Will Avoid Chimerix Like the Plague.
August 11, 2023
CMRX stock may seem like a high-risk, high-potential play, but it makes sense why the market has bid down this biotech.
Via
InvestorPlace
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.